𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy

✍ Scribed by Austin K. Mattox; Amy L. Lark; D. Cory Adamson

Book ID
116370227
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
891 KB
Volume
114
Category
Article
ISSN
0303-8467

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Response to low dose temozolomide in rad
Response to low dose temozolomide in radiation induced gliomatosis cerebri
✍ Hargrave, D. ;Bouffet, E. ;Gammon, J. ;Becker, L. ;Rutka, J. ;Baruchel, S. πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

{ Sylvain Baruchel is the Principal Investigator of an industry sponsored study (Schering-Plough). He receives no monetary compensation. Grant sponsor: Temodal 1 (the manufacturers of temozolomide), Schering Plough, Inc. (for the Phase I Clinical Trial).

Breast cancer subtypes and response to s
Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases
✍ Anna NiwiΕ„ska; Magdalena Murawska; Katarzyna Pogoda πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after whole‐brain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients